SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Cafe Blitz
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: delnig who wrote (269)9/10/1998 6:49:00 PM
From: Blitz  Read Replies (2) of 293
 
AXPH

With a 52wk high of almost $16,
and looking at the recent chart activity,
it looks pretty good, except for the large spread.
Will keep an eye on it...

Here is what they do:
AXYS Pharmaceuticals, Inc., is engaged in gene
identification through clinical development and is focused on the discovery of small molecule therapeutics. For the 3 months ended 3/31/98, revenues increased 26% to $8.4M. Net loss totalled $135M, up from $2M. Revenues reflect higher revenues under collaborative agreements with BMS and PD.
Higher loss reflects a $124.9M acquired in process research and development expense.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News